Specific plasmids encoding shRNA molecules directed against growth factor receptors in cell proliferation inhibition and induction phenotype changes relevant to enhancement of anti-tumor immunity. Model of human non-small (NSCLC) and small (SCLC) cell lung cancer lines

P. Kopinski, J. Kowalewski, A. Goc, M. Jankowski, M. Dancewicz, E. Polgesek (Bydgoszcz, Torun, Poland)

Source: Annual Congress 2010 - Pathology of lung cancer
Session: Pathology of lung cancer
Session type: Thematic Poster Session
Number: 3255
Disease area: Thoracic oncology

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. Kopinski, J. Kowalewski, A. Goc, M. Jankowski, M. Dancewicz, E. Polgesek (Bydgoszcz, Torun, Poland). Specific plasmids encoding shRNA molecules directed against growth factor receptors in cell proliferation inhibition and induction phenotype changes relevant to enhancement of anti-tumor immunity. Model of human non-small (NSCLC) and small (SCLC) cell lung cancer lines. Eur Respir J 2010; 36: Suppl. 54, 3255

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Phenotype pattern of human non-small cell lung cancer (NSCLC) model line in immune escape phenomenon. Effect of transfection with plasmids encoding specific anti-EGFR1 and anti-HER2/neu short hairpin (SH)RNA sequences
Source: Annual Congress 2009 - Basic science and lung cancer
Year: 2009


Targeting gene of insulin-like growth factor type I (IGF-I) on in vitro model of A549 cell line with triple-helix approach. Perspectives of gene therapy in non-small cell lung (NSCLC) cancer
Source: Eur Respir J 2006; 28: Suppl. 50, 387s
Year: 2006

Inhibition of insulin-like growth factor type I (IGF-I) gene in A549 human lung cancer cell line enhances cell apoptosis and causes phenotype changes relevant to increased tumor susceptibility to immune system
Source: Eur Respir J 2007; 30: Suppl. 51, 715s
Year: 2007

Inhibition of B7-H4 gene expression by RNA interference (RNAi) in lung cancer A549 cell line
Source: Annual Congress 2011 - Progress in pathology of lung cancer
Year: 2011

Functional expressions of EGFP/LKB1 and its kinase domain induced apoptosis and enhanced chemosensitivity in lung cancer cell lines
Source: Eur Respir J 2004; 24: Suppl. 48, 5s
Year: 2004

Downregulation of expression growth factor receptor induced by vector-based siRNA and its effect on radiosensitivity of pulmonary adenocarcinoma cell line
Source: Eur Respir J 2006; 28: Suppl. 50, 810s
Year: 2006

MiR-34a favours macrophage polarization switch from M2 to M1 phenotype in non small cell lung cancer (NSCLC)
Source: Virtual Congress 2020 – Molecular alterations and immunology in lung cancer
Year: 2020


Toll-like receptor 3 is up-regulated and enhances anti-proliferative function in human non-small cell lung cancer
Source: Annual Congress 2008 - Lung cancer and other malignant diseases involving the lungs
Year: 2008

Cyclooxygenase(COX)-2 is over-expressed in non small cell lung cancer (NSCLC) and is a potential target for treatment
Source: Eur Respir J 2002; 20: Suppl. 38, 400s
Year: 2002

Expression of vascular endothelial growth factor (VEGF) and association with lymphangiogenesis in non small cell (NSCLC) and small cell lung carcinomas (SCLC)
Source: Eur Respir J 2006; 28: Suppl. 50, 386s
Year: 2006

The effects of TNF-α combined with VP16 on growth and cell cycle of lung cancer cell line and the adhesive molecules
Source: Eur Respir J 2002; 20: Suppl. 38, 73s
Year: 2002

Expression of RASGRF2 in non-small cell lung cancer and its effect of transfection on biological behavior of human NSCLC lines H1299
Source: Annual Congress 2012 - New aspects of lung cancer biology
Year: 2012

Humanized S.typhi flagellin (FliC) transfected non-small cell lung cancer (NSCLC) cells induce local inflammatory and necrotic changes in an experimental model
Source: Annual Congress 2011 - Phagocytes and dendritic cells
Year: 2011

Differences of the hypoxia driven gene response in small (H69) and nonsmall (H23) cell lung carcinomas
Source: Eur Respir J 2001; 18: Suppl. 33, 16s
Year: 2001

Inhibition of the effect of epidermal growth factor (EGF) on lung cancer cells. The use of plasmids encoding specific siRNA molecules
Source: International Congress 2015 – Biomarkers, immunology and molecular pathology of lung cancer
Year: 2015

Differences in growth signaling pathway activation in small cell and non-small cell carcinomas of the lung
Source: Eur Respir J 2006; 28: Suppl. 50, 326s
Year: 2006

Choice of endogenous control for gene expression in nonsmall cell lung cancer
Source: Eur Respir J 2005; 26: 1002-1008
Year: 2005



HIF-1α modulation by topoisomerase inhibitors in A549, a non-small cell lung cancer cell line
Source: Annual Congress 2007 - Biology in thoracic oncology
Year: 2007


Espression of vascular endothelial growth factor (VEGF) and its receptors (VEGF-R1-Flt1, VEGF-R2-Flk1) in non small cell (NSCLC) and small cell lung carcinomas (SCLC). Correlation with clinical outcome
Source: Annual Congress 2008 - Biology in thoracic tumours
Year: 2008


Inhibitory effects of shRNA targeting layilin on adhesion and invasion behavior of human lung carcinoma cell A549 induced by hyaluronan in vitro
Source: Eur Respir J 2006; 28: Suppl. 50, 855s
Year: 2006